Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1400 of 3173 entries
View as:

COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States

Phase: N/A Priority: Normal
NCT ID: NCT05020145 Org: User:
Start: 08/25/21 End: 12/17/21 Due: 12/17/22

Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments

Phase: N/A Priority: Normal
NCT ID: NCT04175262 Org: User:
Start: 10/31/19 End: 03/09/20 Due: 03/09/21

A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib

Phase: N/A Priority: Normal
NCT ID: NCT02334800 Org: User:
Start: 03/31/15 End: 10/09/16 Due: 10/09/17

A Single Oral Dose Study Of PF-06409577 In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02286882 Org: User:
Start: 11/30/14 End: 06/30/15 Due: 06/30/16

A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.

Phase: N/A Priority: Normal
NCT ID: NCT00437489 Org: User:
Start: 06/30/07 End: 12/31/07 Due: 12/31/08

Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT05061446 Org: User:
Start: 09/10/21 End: 10/06/23 Due: 10/06/24

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01975389 Org: User:
Start: 10/29/13 End: 04/03/17 Due: 04/03/18

Multicenter, Open, Randomized Comparative Trial To Compare The Efficacy Of Azithromycin Versus Amoxicillin In Children With Strep Throat

Phase: N/A Priority: Normal
NCT ID: NCT00643539 Org: User:
Start: 12/31/02 End: 07/31/03 Due: 07/31/04

Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00051844 Org: User:
Start: 08/31/02 End: 11/30/04 Due: 11/30/05

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT00036218 Org: User:
Start: 12/31/01 End: 04/30/03 Due: 04/30/04

A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00886821 Org: User:
Start: 10/31/08 End: 06/30/11 Due: 06/30/12

The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin

Phase: N/A Priority: Normal
NCT ID: NCT01435655 Org: User:
Start: 11/30/11 End: 02/28/14 Due: 02/28/15

Phase1, Single Dose, Crossover Study to Determine Bioequivalence

Phase: N/A Priority: Normal
NCT ID: NCT00786240 Org: User:
Start: 01/31/09 End: 02/28/09 Due: 02/28/10

A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01829048 Org: User:
Start: 03/06/13 End: 10/17/13 Due: 10/17/14

Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859

Phase: N/A Priority: Normal
NCT ID: NCT02766621 Org: User:
Start: 05/27/16 End: 09/26/17 Due: 09/26/18

An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01066546 Org: User:
Start: 04/30/10 End: 07/31/10 Due: 07/31/11

Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02055976 Org: User:
Start: 03/31/14 End: 01/31/15 Due: 01/31/16

A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

Phase: N/A Priority: Normal
NCT ID: NCT01920061 Org: User:
Start: 09/10/13 End: 01/08/20 Due: 01/08/21

A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections

Phase: N/A Priority: Normal
NCT ID: NCT00994890 Org: User:
Start: 11/17/09 End: 03/01/11 Due: 03/01/12

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Phase: N/A Priority: Normal
NCT ID: NCT01371721 Org: User:
Start: 02/29/12 End: 10/31/15 Due: 10/31/16

Users Study Of The Caverject Delivery System

Phase: N/A Priority: Normal
NCT ID: NCT01747928 Org: User:
Start: 03/31/13 End: 03/31/13 Due: 03/31/14

Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00808132 Org: User:
Start: 01/31/09 End: 02/28/11 Due: 02/28/12

Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00962780 Org: User:
Start: 03/31/10 End: 04/30/13 Due: 04/30/14

A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT00267267 Org: User:
Start: 01/31/06 End: 01/31/07 Due: 01/31/08

Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes

Phase: N/A Priority: Normal
NCT ID: NCT01258738 Org: User:
Start: 02/28/11 End: 10/31/14 Due: 10/31/15